Matthew R Hayes Selected Research

Islet Amyloid Polypeptide Receptors

11/2019	Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss.
12/2017	Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.
6/2015	Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake.
8/2013	Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew R Hayes Research Topics

Disease

34	Body Weight (Weight, Body) 01/2022 - 01/2010
32	Obesity 01/2022 - 08/2007
16	Nausea 01/2022 - 04/2012
13	Vomiting 01/2022 - 09/2012
9	Anorexia 01/2022 - 01/2016
9	Weight Loss (Weight Reduction) 01/2022 - 08/2007
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2011
6	Pica (Geophagia) 01/2020 - 04/2012
3	Diabetes Mellitus 06/2012 - 07/2010
2	Opioid-Related Disorders (Opiate Addiction) 12/2021 - 01/2021
2	Weight Gain 07/2021 - 12/2011
2	AIDS-Related Complex (ARC) 01/2021 - 02/2016
2	Body Weight Changes 01/2019 - 01/2018
2	Insulin Resistance 01/2018 - 12/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 08/2007
2	Hyperphagia (Overeating) 01/2015 - 01/2010
2	Cognitive Dysfunction 07/2014 - 09/2012
1	Neuroinflammatory Diseases 01/2022
1	Glaucoma 01/2022
1	Pain (Aches) 01/2021
1	Morning Sickness 01/2020
1	Gliosis 01/2020
1	Neoplasms (Cancer) 01/2020
1	Pediatric Obesity 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 05/2017
1	Substance-Related Disorders (Drug Abuse) 06/2016
1	Feeding and Eating Disorders (Eating Disorder) 06/2016
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2016
1	Fatigue 01/2016

Drug/Important Bio-Agent (IBA)

21	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 07/2010
16	Glucagon-Like Peptide-1 ReceptorIBA 11/2021 - 03/2011
11	LeptinIBA 01/2021 - 08/2007
9	Islet Amyloid PolypeptideIBA 01/2021 - 08/2013
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
7	Exenatide (Byetta)FDA Link 01/2021 - 07/2011
7	Liraglutide FDA Link 01/2020 - 07/2011
6	Peptides (Polypeptides)IBA 01/2022 - 08/2007
6	Pharmaceutical PreparationsIBA 11/2021 - 06/2012
5	Appetite Depressants (Anorectics)IBA 01/2020 - 03/2016
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 04/2012
4	Islet Amyloid Polypeptide ReceptorsIBA 11/2019 - 08/2013
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022 - 01/2018
3	LigandsIBA 11/2021 - 08/2008
3	muskIBA 11/2021 - 01/2020
3	EmeticsIBA 11/2021 - 01/2020
3	Sucrose (Saccharose)IBA 07/2021 - 01/2010
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 05/2021 - 06/2011
3	Blood Glucose (Blood Sugar)IBA 08/2017 - 02/2014
3	Nicotine FDA Link 05/2017 - 09/2012
3	Biological ProductsIBA 01/2017 - 12/2011
2	gastric inhibitory polypeptide receptorIBA 01/2022 - 11/2021
2	Growth Differentiation Factor 15IBA 01/2022 - 01/2020
2	neuropeptide Y2 receptorIBA 12/2021 - 01/2021
2	melanotan-IIIBA 05/2021 - 09/2012
2	Cocaine (Cocaine HCl)IBA 01/2021 - 01/2018
2	Dimenhydrinate (DMH)FDA LinkGeneric 01/2021 - 01/2018
2	Calcitonin Receptors (Calcitonin Receptor)IBA 01/2021 - 02/2016
2	MelanocortinsIBA 01/2020 - 09/2012
2	salmon calcitonin (Calcimar)FDA LinkGeneric 11/2019 - 12/2017
2	Proglucagon (Glucagon Precursors)IBA 11/2019 - 01/2016
2	exendin (9-39)IBA 01/2016 - 04/2012
2	Small Interfering RNA (siRNA)IBA 01/2015 - 01/2010
2	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2014 - 09/2012
2	Cholecystokinin (Pancreozymin)IBA 01/2010 - 08/2007
1	corrinIBA 01/2022
1	Peptide YYIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 12/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2021
1	salicylhydroxamic acid (SHAM)IBA 07/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2021
1	IncretinsIBA 01/2021
1	Type 3 Melanocortin ReceptorIBA 01/2020
1	CytokinesIBA 01/2020
1	AdipokinesIBA 01/2020
1	SHU 9119IBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Uncoupling Protein 1IBA 01/2018
1	Hormones (Hormone)IBA 12/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	HDL CholesterolIBA 01/2017
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 02/2016
1	ClayIBA 01/2016
1	AntiemeticsIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	KaolinIBA 01/2016
1	pyrrolidonyl-beta-naphthylamideIBA 12/2014
1	Donepezil (Aricept)FDA LinkGeneric 07/2014
1	Kainic Acid Receptors (Kainate Receptor)IBA 05/2014

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2021 - 03/2011
5	Therapeutics 11/2021 - 11/2019
4	Glycemic Control 01/2022 - 01/2020
2	Self Administration (Administration, Self) 07/2014 - 09/2012
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2017
1	Gastrectomy 01/2017
1	Injections 01/2016